Anti-spike Antibody Status in Pre-vaccinated Healthy Participants and Rheumatoid Arthritis Patients During the Third Wave of COVID-19

Introduction Anti-spike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies produced after infection with the coronavirus disease of 2019 (COVID-19) will offer protection and prevent re-infection for a few months. Seroprevalence studies measuring the SARS‑CoV-2 immunoglobulin G (...

Descripción completa

Detalles Bibliográficos
Autores principales: Eerike, Madhavi, Sundaramurthy, Raja, Gandham, Ravi, Sakthivadivel, Varatharajan, Amshala, Aravind, Priyadarshini, Rekha, Pyati, Anand K, Patil, Parag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167490/
https://www.ncbi.nlm.nih.gov/pubmed/37181975
http://dx.doi.org/10.7759/cureus.37316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167490/
https://www.ncbi.nlm.nih.gov/pubmed/37181975
http://dx.doi.org/10.7759/cureus.37316

Ejemplares similares